Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sabin

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
International Journal of Epidemiology|December 29, 2020
Cohort Profile: The St. Jude Lifetime Cohort Study (SJLIFE) for paediatric cancer survivorsCarrie R Howell, Kari L Bjornard, Kirsten K Ness, et al.
Cancer|October 13, 2021
Primary hypothyroidism in childhood cancer survivors: Prevalence, risk factors, and long-term consequencesWassim Chemaitilly, Zhenghong Li, Tara M Brinkman, et al.
The Lancet. Oncology|April 12, 2021
Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupDaniel C Bowers, Lisanne C Verbruggen, Leontien C M Kremer, et al.
Neuro-Oncology|July 28, 2023
High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experienceJason Chiang, Aditi Bagchi, Xiaoyu Li, et al.
Neuro-Oncology Advances|November 13, 2024
Development of the pediatric neuro-oncology services assessment aid: An assessment tool for pediatric neuro-oncology service delivery capacityRevathi Rajagopal, Rosdali Diaz Coronado, Syed Ahmer Hamid, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Acta Neuropathologica|June 18, 2018
Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomasKristian W Pajtler, Ji Wen, Martin Sill, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
International Journal of Epidemiology|December 29, 2020
Cohort Profile: The St. Jude Lifetime Cohort Study (SJLIFE) for paediatric cancer survivorsCarrie R Howell, Kari L Bjornard, Kirsten K Ness, et al.
Cancer|October 13, 2021
Primary hypothyroidism in childhood cancer survivors: Prevalence, risk factors, and long-term consequencesWassim Chemaitilly, Zhenghong Li, Tara M Brinkman, et al.
The Lancet. Oncology|April 12, 2021
Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupDaniel C Bowers, Lisanne C Verbruggen, Leontien C M Kremer, et al.
Neuro-Oncology|July 28, 2023
High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experienceJason Chiang, Aditi Bagchi, Xiaoyu Li, et al.
Neuro-Oncology Advances|November 13, 2024
Development of the pediatric neuro-oncology services assessment aid: An assessment tool for pediatric neuro-oncology service delivery capacityRevathi Rajagopal, Rosdali Diaz Coronado, Syed Ahmer Hamid, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Acta Neuropathologica|June 18, 2018
Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomasKristian W Pajtler, Ji Wen, Martin Sill, et al.
Pageof 11